Close
Accessibility and reading comfort
Text size
Decrease text size
Increase text size
Light/Dark mode
Light mode
Dark mode
Lines vertical spacing
Decrease lines vertical spacing
Increase lines vertical spacing
Accessibility
More about accessibility
Reset to default values
Trouble using our website?
Contact us
Tools
Go to menu
Go to content
Go to search
CPMS
REDgistry
Elearning
Members area
Accessibility
Search
Search
What are you looking for?
Search
×
About
The ERNs
The ERN initiative
Evaluation and continuous monitoring
ERN-EYE
ERN-EYE presentation
ERN-EYE flyer
The ERN EYE Team
ePAG
Rare diseases stakeholders
ERN-EYE newsletters
News
Events
Resources
Diseases
Research
What is clinical research?
Clinical trials by disease
Scientific publications
See My Life research project
Call for collaborations
Funding opportunities
Patients
Cross-border information
ePAG
Healthcare Experts
ERN-EYE Members
Members
HCP Centers
Team & WG Leaders
CPMS
All about the CPMS
CPMS GREET Meetings
CPMS RED-VAR Meetings
ERN-EYE consensus statements
Bardet-Biedl syndrome
Learn
E-Learning
Inherited Retinal Diseases
ERN-EYE e-learning program on Paediatric Rare Eye Diseases
ERN-EYE good practices series
ERN-EYE short exchange program
ERN-EYE Webinars
ERN-EYE Serious Game
RD landscape
National Integration
JARDIN Joint Action
ERNs care for Ukraine
ERICA
ERNs Scientific Publications
PROMs Repository
Webinars
ERDERA
Act4RED
X
Home
Scientific Publications
The need for widely available genomic testing in rare eye diseases: an ERN‑EYE position statement
The need for widely available genomic testing in rare eye diseases: an ERN‑EYE position statement
